These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 18249172)

  • 41. Dietary supplementation with Pluronic L-81 modifies hepatic secretion of very low density lipoproteins in the rat.
    Manowitz NR; Tso P; Drake DS; Frase S; Sabesin SM
    J Lipid Res; 1986 Feb; 27(2):196-207. PubMed ID: 3958622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
    Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
    Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation of hepatic steatosis to atherogenic dyslipidemia.
    Makadia SS; Blaha M; Keenan T; Ndumele C; Jones S; DeFilippis A; Martin S; Kohli P; Conceicao R; Carvalho J; Nasir K; Blumenthal R; Santos RD
    Am J Cardiol; 2013 Nov; 112(10):1599-604. PubMed ID: 24012029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.
    Shimano H; Yamada N; Katsuki M; Shimada M; Gotoda T; Harada K; Murase T; Fukazawa C; Takaku F; Yazaki Y
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1750-4. PubMed ID: 1542669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.
    López-Oliva ME; Garcimartin A; Muñoz-Martínez E
    Br J Nutr; 2017 Dec; 118(11):914-929. PubMed ID: 29173234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The metabolic and pharmacologic bases for treating atherogenic dyslipidaemia.
    Chan DC; Barrett PH; Watts GF
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):369-85. PubMed ID: 24840265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
    Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
    J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of insulin-sensitising agents in mice with hepatic insulin resistance.
    Cohen SE; Tseng YH; Michael MD; Kahn CR
    Diabetologia; 2004 Mar; 47(3):407-411. PubMed ID: 14730378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.
    Shimizu-Albergine M; Basu D; Kanter JE; Kramer F; Kothari V; Barnhart S; Thornock C; Mullick AE; Clouet-Foraison N; Vaisar T; Heinecke JW; Hegele RA; Goldberg IJ; Bornfeldt KE
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34491909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic insulin resistance directly promotes formation of cholesterol gallstones.
    Biddinger SB; Haas JT; Yu BB; Bezy O; Jing E; Zhang W; Unterman TG; Carey MC; Kahn CR
    Nat Med; 2008 Jul; 14(7):778-82. PubMed ID: 18587407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism.
    Moon JH; Kim HJ; Kim HM; Choi SH; Lim S; Park YJ; Jang HC; Cha BS
    Thyroid; 2013 Sep; 23(9):1057-65. PubMed ID: 23517243
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility.
    Weng W; Breslow JL
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14788-94. PubMed ID: 8962133
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.
    Lede V; Franke C; Meusel A; Teupser D; Ricken A; Thiery J; Schiller J; Huster D; Schöneberg T; Schulz A
    PLoS One; 2016; 11(12):e0167888. PubMed ID: 28030540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Atherogenic dyslipidemia and the metabolic syndrome: pathophysiological mechanisms].
    Zák A; Slabý A
    Cas Lek Cesk; 2008; 147(9):459-70. PubMed ID: 18988488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.